Cytori Therapeutics Inc Series S Warrant
CYTXZ
CYTXZ was delisted on the 23rd of July, 2019.
7 hedge funds and large institutions have $427K invested in Cytori Therapeutics Inc Series S Warrant in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
968% more capital invested
Capital invested by funds: $40K → $427K (+$387K)
17% more funds holding
Funds holding: 6 → 7 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$9.97K |
Top Sellers
CYTXZ Hedge Fund Activity: Q3 2018 in Review
7 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Cytori Therapeutics Inc Series S Warrant (CYTXZ) for Q3 2018, worth a combined $427K — up 968% from $40K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CYTXZ positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $9.97K.
- 7 institutional investors held Cytori Therapeutics Inc Series S Warrant (CYTXZ) as of Q3 2018, up from 6 in Q2 2018.
- Funds reported $427K of Cytori Therapeutics Inc Series S Warrant stock for Q3 2018, up 968% quarter-over-quarter.
- 1 fund opened new Cytori Therapeutics Inc Series S Warrant positions in Q3 2018 and 0 closed out, a net change of +1 holder.
- The largest Cytori Therapeutics Inc Series S Warrant buyer in Q3 2018 was Anson Funds Management, an estimated $9.97K added.
Based on aggregated 13F filings for Q3 2018.